Editorial Board Disclosure Policy
(Last updated February 2022)
All editors responsible for recommending or making publication decisions are requested to disclose on an annual basis any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content.
The following competing interests were disclosed:
Kate Brian – Financial activities: paid staff member at patient charity Fertility Network UK and paid for lay work for HEE. Intellectual property: author of five books but do not receive royalties. Involvement with other peer-reviewed publications: none, but I edit the Journal of Fertility Counselling.
Antonio Capalbo – Financial activities: full time employee of Igenomix. Personal fees: Speaker honoraria from Merck.
Ying Cheong – Financial activities: Associate Dean Enterprise for University of Southampton, Director of Complete Fertility, Patent holder EP18779745.1. Personal fees: Speaker fees from Merck. Intellectual property: Patent holder EP18779745.1. Involvement with other peer-reviewed publications: Editorial Board Member for Scientific Reports, Human Fertility.
Rohan Chodankar – Financial activities: I have received salary support in my role as a clinical research fellow at the University of Edinburgh from Bayer AG, Berlin.
Pierre Comizzoli – Involvement with other peer-reviewed publications: Associate Editor of Journal of Assisted Reproduction and Genetics and Theriogenology. Treasurer of the International Embryo Technology Society. Board director of the National Academy of Inventors.
Wei Cui – Financial activities: Currently hold faculty start-up funds from University of Massachusetts Amherst and grant from NICHD of National Institutes of Health. Personal fees: Honorarium received from the Cold Spring Harbor Laboratory in 2018. Involvement with other peer-reviewed publications: Academic Editor for PeerJ and PLOS One; Associate Editor for Journal of Cellular and Molecular Medicine and Frontiers in Veterinary Science (Section: Animal Reproduction).
W Colin Duncan – Personal Fees: Spoken at meetings supported by Merck and Guerbet. Received grant support from Galvani Biosciences. Involvement with other peer-reviewed publications: Past chair of Society of Reproduction and Fertility.
Andrew Horne – Financial activities: Andrew Horne has served as a consultant for AbbVie, Roche Diagnostics, Ferring and Nordic Pharma. Involvement with other peer-reviewed publications: Chair of RCOG Academic Board (2017–current day), Board Member of the Society of Endometriosis and Uterine Disorders (2018-current day), Board Member Association of Early Pregnancy Units (2018–current day), Ambassador to the World Endometriosis Society (2018–current day), UK Representative for ESHRE (2018-current day), Board Member of the UKRI Advanced Pain Discovery Platform Initiative (2020–current day).
Francesca Klinger – Financial activities: Research grant from Merck. Personal fees: Received webinar fee from Merck.
Mathew Leonardi – Financial activities: Research grant from Hyivy Health. Personal fees: Fees for consulting – AbbVie; Honoraria – Bayer, TerSera; Freelance writing – Skyword/GE Healthcare. Non-financial support: Accommodation paid for by International Society of Ultrasound in Obstetrics and Gynecology for World Congress Berlin 2019 and World Congress Singapore 2018. Registration for International Society of Ultrasound in Obstetrics and Gynecology for World Congress 2020, 2021. Registration for AIUM 2022. Involvement with other peer-reviewed publications: Editorial Board Member of The Journal of Minimally Invasive Gynecology and Ultrasound in Obstetrics and Gynecology.
Raymond Li – Financial activities: Received financial support for company-initiated research from Ferring Pharmaceuticals. Involvement with other peer-reviewed publications: Associate Editor, BMJ Sexual and Reproductive Health, Associate Editor, Human Reproduction Open, Editorial Board Member, BJOG, Guest Editor, Frontiers in Endocrinology.
Federica Lopes – Financial activities: Research Fellow at the University of Edinburgh. Principal Investigator in Deanery of Clinic Sciences Funding Challenge Award for a project entitled ‘Which DNA damage response/pathway(s) are activated in spermatogonial stem cells after exposure to chemotherapy?’ (£2,494.88) – 2020. Principal Investigator in the SRF Academic Scholarship Award for the project entitled ‘The impact of the cell cycle of prepubertal testicular germline stem cells on the sensitivity to chemotherapy-induced damage’ (£10,100). Non-financial support: Society for Reproduction and Fertility Travel Grant 2018 (£650). Invited speaker at 3rd medAlp Regio Congress, Gynaecological pathologies and Infertility, 11th–12th October 2019, Bolzano, Italy (oral presentation).
Sarah Martins da Silva – Financial activities: Previous research funding from AstraZeneca (2017 – 2019; £103,710). Personal fees: Pharmasure advisory board June 2019. Honorarium/fees from British Dietetic Association, ESHRE, expert testimony and Bioscientifica – paid to Reproductive Medicine Research Group, Cooper Surgical webinar (April 2021) and podcast (June 2021) fees, Merck speaker’s fees (November 2021). Non-financial support: Travel and accommodation support from Pharmasure Ltd to attend ESHRE 2019, travel and accommodation support from Gideon Richter to attend Fertility 2020, travel and accommodation support from Merck to attend SMART masterclass 2021. Involvement with other peer-reviewed publications: Associate Editor for Human Reproduction, Royal Anniversary Trust reader’s panel.
Claudia Massarotti – Personal Fees: Consulting activity (Roche), honoraria (IPSEN, MERCK). Non-financial support: Payment for travel expenses (MSD, IBSA).
Amanda De Mestre – Financial activities: Currently hold grants from the Horserace betting levy board, Thoroughbred Breeders Association and Alborada Trust for research performed in the laboratory. Personal fees: Employee of the Royal Veterinary College, University of London. Occasional fees paid for the delivery of a lecture(s) at veterinary CPD events, various venues, countries and organisations. Non-financial support: Travel paid to attend meetings to perform roles as member of Society of Reproduction and Fertility Council and as committee member and Treasurer of the International Symposium for Equine Reproduction. Involvement with other peer-reviewed publications: Associate Editor for Frontiers in Reproduction and Endocrinology.
Chelsea Morroni – Involvement with other peer-reviewed publications: I am currently serving on the editorial board of Contraception and as Specialty Chief Editor for Frontiers in Global Women’s Health.
Brett Nixon – Involvement with other peer-reviewed publications: I am currently serving as an Associate Editor for Molecular Human Reproduction, Frontiers in Endocrinology (sub-section: Reproduction) and the Asian Journal of Andrology. I also hold the position of Section Editor (Gametogenesis and fertilization) for BMC Developmental Biology.
Richard Quinton – Personal fees: Sandoz: Speaker honorarium (2019) – £500, Bayer: Speaker honoraria (2019)– £1,000, Thornton & Ross: Speaker honorarium (March 2021) – £500, Sandoz: Speaker honorarium (Nov 2021) – £1,200, Besins: Speaker honorarium (Dec 2021) – £1,600, Besins: Speaker honorarium (May 2022) – £1,600. Involvement with other peer-reviewed publications: Therapeutic Advances in Endocrinology & Metabolism, Minerva Endocrinologica, Journal of Clinical & Scientific Research.
Cecilia Sjoblom – Personal fees: Honorarium for teaching and training initiatives sponsored by MERCK and VITROLIFE. Non-Financial support: Occasional conference attendance support from MERCK / FERRING / MSD / VITROLIFE. Intellectual property: Method and Medium for In Vitro culture of Human Embryos, Patent Number US 6605468 / EP 1088057 B1; PCT/AU1999/000499/ WO1999067364, Method and medium for the propagation of early stage embryos to blastocyst stage. The medium contains an effective amount of human GM-CSF to increase the percentage of pre-blastocyst embryos, which develop to transfer ready blastocysts. I receive no royalties or payment relating to this patent.
Norah Spears – Personal fees: 2017: Expert consultant for Karolinska Institute, Sweden, for Professor in Physiology of Reproduction. 2016–17: Expert consultant for AstraZeneca, providing professional input and expertise in ovarian folliculogenesis. Royalties for work as Editor of: Cancer treatment and the ovary: Clinical and laboratory analysis of ovarian toxicity. Eds RA Anderson and N Spears. 2015, Published by Elsevier; pp166; ISBN 9780128015919 (print) / 9780128016015 (eBook). 2019–2023: External Examiner for MSc in Reproductive & Developmental Biology at Imperial College, London (paid appointment). Involvement with other peer-reviewed publications: Member of Editorial Board of Current Opinion in Physiology: 2017–2020. 2020–2021: Guest Editor (with Professor K Hardy, Imperial College London) for special issue on ovary development in Current Opinion in Endocrine and Metabolic Research.
Claire Stenhouse – Personal fees: Full time employee of Texas A&M Agrilife Research.
Carla Tomassetti – Financial activities: In the past 2 years: Consultancy (paid to institution, no private revenue) for Merck SA (including speaker’s fee), Nordic Pharma (ended 2020), Gedeon Richter (ongoing). Supervisor of a clinical research fellowship at UZ Leuven granted by Merck SA. ESHRE: core member of the working group for the update of the Endometriosis Guideline, member of the working group on Endometriosis Classification, past coordinator of Special Interest Group Endometriosis and Endometrial Disorders. Personal fees: Speaker’s fee by Merck SA (paid to institution, no private revenue). Non-financial support: Sponsoring to attend scientific meetings by (no private revenue) by Merck SA, Ferring Pharmaceuticals, Gedeon Richter.
Adam Watkins – Personal fees: Payment for time and services as external examiner at the University of Southampton and Imperial College London, in 2021. I will continue my role as external examiner for the University of Southampton in 2022.
Nick Wheelhouse – Personal fees: External Examiner Role, Royal Veterinary College (2019 to present), PhD Examiner, University College Dublin (2021), Visiting Lecturer, University of Liverpool (2018, 2020, 2022). Non-financial support: Travel expenses paid by Ceva Santé Animale to speak at British Cattle Veterinary Association 2019. Involvement with other peer-reviewed publications: Associate Editor, Veterinary Science (2021 to present), Associate Editor, Frontiers in Veterinary Science (2019–2022); Associate Editor, Heliyon (2015–2020).
Jack Wilkinson – Financial activities: Currently hold research grants from NIHR. Personal fees: Paid peer review for BJOG: An international journal of obstetrics and gynaecology. Involvement with other peer-reviewed publications: Stats Review Panel, BJOG: An international journal of obstetrics and gynaecology; Stats Editor, Cochrane Gynaecology and Fertility; Methodologic Editor, Fertility and Sterility.
Suzannah Williams – Personal fees: Honoraria for being Associate Editor for Reproduction – ended summer 2019. Involvement with other peer-reviewed publications: Associate Editor for Reproduction – ended summer 2019. Member of SRF Council. Chair of Public Engagement and Membership Committee (Jan 2021 to present).
The following editor reported no competing interests:
- Ezekiel Onyonka Mecha
- M Mehdi Ommati
Bioscientifica staff and freelancers working on the journal reported no conflicts of interest. Article authors' declarations are stated in each journal article. Referees must disclose any competing interests before agreeing to review any submission. For more information on the journal’s ethical policy, please read the ethical guidelines.
This policy follows the recommendations of the International Committee of Medical Journals Editors (ICMJE) and the Committee on Publication Ethics (COPE).